发明授权
US08299248B2 Certain 1H-imidazo[4,5-b]pyrazin-2(3H)-ones and 1H-imidazo[4,5-b]pyrazin-2-ols and methods for their use
有权
某些1H-咪唑并[4,5-b]吡嗪-2（3H） - 酮和1H-咪唑并[4,5-b]吡嗪-2-醇及其使用方法
![Certain 1H-imidazo[4,5-b]pyrazin-2(3H)-ones and 1H-imidazo[4,5-b]pyrazin-2-ols and methods for their use](/docs/US/2012-10-30/US08299248B2/abs.jpg.600x600.jpg)
- 专利标题： Certain 1H-imidazo[4,5-b]pyrazin-2(3H)-ones and 1H-imidazo[4,5-b]pyrazin-2-ols and methods for their use
- 专利标题（中）： 某些1H-咪唑并[4,5-b]吡嗪-2（3H） - 酮和1H-咪唑并[4,5-b]吡嗪-2-醇及其使用方法
-
申请号： US12780644申请日： 2010-05-14
-
公开(公告)号： US08299248B2公开(公告)日： 2012-10-30
- 发明人: Aaron Hinken , Fady Malik , Malar Pannirselvam , Alan Russell
- 申请人： Aaron Hinken , Fady Malik , Malar Pannirselvam , Alan Russell
- 申请人地址： US CA South San Francisco
- 专利权人： Cytokinetics, Incorporated
- 当前专利权人： Cytokinetics, Incorporated
- 当前专利权人地址： US CA South San Francisco
- 代理机构： Foley & Lardner LLP
- 主分类号： C07D471/00
- IPC分类号： C07D471/00
![Certain 1H-imidazo[4,5-b]pyrazin-2(3H)-ones and 1H-imidazo[4,5-b]pyrazin-2-ols and methods for their use](/abs-image/US/2012/10/30/US08299248B2/abs.jpg.150x150.jpg)
摘要：
Provided are methods for treating myasthenia gravis in a patient, comprising administering to the patient an effective amount of at least one chemical entity chosen from compounds of Formula I and compounds of Formula II: and pharmaceutically acceptable salts thereof.
公开/授权文献
- US20110014212A1 Certain Chemical Entities, Compositions and Methods 公开/授权日：2011-01-20
信息查询
